glp-1/gip agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Curious how GLP-1 and GIP

Only your doctor can determine which is right for you

The relatively recent advent of incretin-based therapies, synthetic medications that mimic gut hormones to promote insulin production and suppress patients appetites, revolutionized the field

Other online sources are from labs producing peptides that are not meant for human use

Clinical trials showed that 9 out of 10 patients experienced improvement within 4 weeks, with 69% achieving at least a clinically significant reduction in symptoms

Visible changes in firmness, reduced fine lines, and better healing typically appear with consistent use over 48 weeks, as collagen and skin barrier proteins rebuild